POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

0
Player Avatar genedom (97.88) Submitted: 3/10/2014 3:32:41 AM : Outperform Start Price: $8.23 POZN Score: -15.24

A undervalue stock ready to fly high.

Featured Broker Partners


Advertisement